Filed a patent for "kappa opioid receptor agonist-therapeutic antigen binding protein conjugate (ktac) compounds" on Thu, October 12, 2023
Filed a patent for "atopic dermatitis therapy with kappa opioid receptor agonist as adjunct to topical corticosteroid" on Thu, September 14, 2023
Setting up your session...
